1.
Deep learning predicts HER2 status in invasive breast cancer from multimodal ultrasound and MRI. Biomol Biomed [Internet]. 2025 May 16 [cited 2025 Sep. 29];25(10):2243–2251. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/12475